Literature DB >> 18547217

Hypothalamic deep-brain stimulation: target and potential mechanism for the treatment of cluster headache.

A May1.   

Abstract

Recently, functional imaging data have underscored the crucial role of the hypothalamus in trigemino-autonomic headaches, a group of severe primary headaches. This prompted the application of hypothalamic deep-brain stimulation (DBS), with the intention to preventing cluster headache (CH) attacks in selected severe therapy-refractory cases. To date, a total of 50 operated intractable CH patients, one patient with short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing and three with atypical facial pain, have been reported. However, it is not apparent why the spontaneous bursts of activation in the inferior posterior hypothalamus result in excruciating head pain, whereas continuous electrical stimulation of the identical area is able to prevent these attacks. Recently, this issue has been addressed by examining 10 operated chronic CH patients, using H(2)(15)O-positron emission tomography and alternately switching the hypothalamic stimulator on and off. The stimulation-induced activation in the ipsilateral posterior inferior hypothalamic grey (the site of the stimulator tip) as well as activation and de-activation in several cerebral structures belonging to neuronal circuits usually activated in pain transmission. These data argue against an unspecific antinociceptive effect or pure inhibition of hypothalamic activity as the mode of action of hypothalamic DBS and suggest functional modulation of the pain-processing network.

Entities:  

Mesh:

Year:  2008        PMID: 18547217     DOI: 10.1111/j.1468-2982.2008.01629.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  11 in total

1.  Management of cluster headache.

Authors:  Peer C Tfelt-Hansen; Rigmor H Jensen
Journal:  CNS Drugs       Date:  2012-07-01       Impact factor: 5.749

2.  The posterior hypothalamus exerts opposing effects on nociception via the A7 catecholamine cell group in rats.

Authors:  Y Jeong; J R Moes; M Wagner; J E Holden
Journal:  Neuroscience       Date:  2012-10-02       Impact factor: 3.590

Review 3.  Cerebral hemodynamics in the different phases of migraine and cluster headache.

Authors:  Jakob M Hansen; Christoph J Schankin
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-31       Impact factor: 6.200

4.  Neurostimulation for primary headache disorders.

Authors:  Todd J Schwedt
Journal:  Curr Neurol Neurosci Rep       Date:  2009-03       Impact factor: 5.081

Review 5.  New insights into headache: an update on functional and structural imaging findings.

Authors:  Arne May
Journal:  Nat Rev Neurol       Date:  2009-04       Impact factor: 42.937

6.  Posterior hypothalamic modulation of light-evoked trigeminal neural activity and lacrimation.

Authors:  A Katagiri; K Okamoto; R Thompson; D A Bereiter
Journal:  Neuroscience       Date:  2013-04-30       Impact factor: 3.590

7.  Peripheral neuromodulation for the treatment of refractory trigeminal neuralgia.

Authors:  Naum Shaparin; Karina Gritsenko; Diego Fernandez Garcia-Roves; Ushma Shah; Todd Schultz; Oscar DeLeon-Casasola
Journal:  Pain Res Manag       Date:  2015 Mar-Apr       Impact factor: 3.037

8.  Optimal deep brain stimulation site and target connectivity for chronic cluster headache.

Authors:  Harith Akram; Sarah Miller; Susie Lagrata; Marwan Hariz; John Ashburner; Tim Behrens; Manjit Matharu; Ludvic Zrinzo
Journal:  Neurology       Date:  2017-10-13       Impact factor: 9.910

9.  Fornix Stimulation Induces Metabolic Activity and Dopaminergic Response in the Nucleus Accumbens.

Authors:  Hojin Shin; Sang-Yoon Lee; Hyun-U Cho; Yoonbae Oh; In Young Kim; Kendall H Lee; Dong Pyo Jang; Hoon-Ki Min
Journal:  Front Neurosci       Date:  2019-10-24       Impact factor: 4.677

Review 10.  Cluster headache.

Authors:  Elizabeth Leroux; Anne Ducros
Journal:  Orphanet J Rare Dis       Date:  2008-07-23       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.